0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mycosis Fungoides Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-19V1065
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mycosis Fungoides Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Mycosis Fungoides Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-19V1065
Report
December 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mycosis Fungoides Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Mycosis Fungoides Treatment Market

Mycosis Fungoides Treatment Market

Mycosis fungoides is most frequently encountered in primary cutaneous lymphoma. The disease progression is slow and indolent with a challenging diagnosis in the early stage of the disease which requires accurate clinical-histopathological correlation. It is a rare disease occurs usually in adults above 50 years of age, the ratio of its occurrence in men to women is 2:1.
Market Analysis and Insights: Global Mycosis Fungoides Treatment Market
The global Mycosis Fungoides Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Mycosis Fungoides Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mycosis Fungoides Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Mycosis Fungoides Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mycosis Fungoides Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mycosis Fungoides Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mycosis Fungoides Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Mycosis Fungoides Treatment Market Report

Report Metric Details
Report Name Mycosis Fungoides Treatment Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astellas Pharma, Bayer AG, Dover Medical and Scientific Equipment, Ltd., Elorac, Inc., Kyowa Kirin, Inc., Macopharma, Soligenix, Inc., Varian Medical Systems, Yaupon Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Mycosis Fungoides Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Mycosis Fungoides Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycosis Fungoides Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Mycosis Fungoides Treatment Market report?

Ans: The main players in the Mycosis Fungoides Treatment Market are Astellas Pharma, Bayer AG, Dover Medical and Scientific Equipment, Ltd., Elorac, Inc., Kyowa Kirin, Inc., Macopharma, Soligenix, Inc., Varian Medical Systems, Yaupon Therapeutics

What are the Application segmentation covered in the Mycosis Fungoides Treatment Market report?

Ans: The Applications covered in the Mycosis Fungoides Treatment Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Mycosis Fungoides Treatment Market report?

Ans: The Types covered in the Mycosis Fungoides Treatment Market report are Topical Steroids, Mechlorethamine Gel, HDAC Inhibitors, Monoclonal Antibodies, Localized Radiation Therapy, Extracorporeal Photopheresis, Others

Recommended Reports

Lymphoma & Blood Cancer

Dermatology & Skin Disease

Cancer Therapy Advancements

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycosis Fungoides Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Topical Steroids
1.2.3 Mechlorethamine Gel
1.2.4 HDAC Inhibitors
1.2.5 Monoclonal Antibodies
1.2.6 Localized Radiation Therapy
1.2.7 Extracorporeal Photopheresis
1.2.8 Others
1.3 Market by Application
1.3.1 Global Mycosis Fungoides Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycosis Fungoides Treatment Market Perspective (2019-2030)
2.2 Global Mycosis Fungoides Treatment Growth Trends by Region
2.2.1 Mycosis Fungoides Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycosis Fungoides Treatment Historic Market Size by Region (2019-2024)
2.2.3 Mycosis Fungoides Treatment Forecasted Market Size by Region (2025-2030)
2.3 Mycosis Fungoides Treatment Market Dynamics
2.3.1 Mycosis Fungoides Treatment Industry Trends
2.3.2 Mycosis Fungoides Treatment Market Drivers
2.3.3 Mycosis Fungoides Treatment Market Challenges
2.3.4 Mycosis Fungoides Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Mycosis Fungoides Treatment by Players
3.1.1 Global Mycosis Fungoides Treatment Revenue by Players (2019-2024)
3.1.2 Global Mycosis Fungoides Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mycosis Fungoides Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Mycosis Fungoides Treatment Market Concentration Ratio
3.4.1 Global Mycosis Fungoides Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Treatment Revenue in 2023
3.5 Global Key Players of Mycosis Fungoides Treatment Head office and Area Served
3.6 Global Key Players of Mycosis Fungoides Treatment, Product and Application
3.7 Global Key Players of Mycosis Fungoides Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycosis Fungoides Treatment Breakdown Data by Type
4.1 Global Mycosis Fungoides Treatment Historic Market Size by Type (2019-2024)
4.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Type (2025-2030)
5 Mycosis Fungoides Treatment Breakdown Data by Application
5.1 Global Mycosis Fungoides Treatment Historic Market Size by Application (2019-2024)
5.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycosis Fungoides Treatment Market Size (2019-2030)
6.2 North America Mycosis Fungoides Treatment Market Size by Type
6.2.1 North America Mycosis Fungoides Treatment Market Size by Type (2019-2024)
6.2.2 North America Mycosis Fungoides Treatment Market Size by Type (2025-2030)
6.2.3 North America Mycosis Fungoides Treatment Market Share by Type (2019-2030)
6.3 North America Mycosis Fungoides Treatment Market Size by Application
6.3.1 North America Mycosis Fungoides Treatment Market Size by Application (2019-2024)
6.3.2 North America Mycosis Fungoides Treatment Market Size by Application (2025-2030)
6.3.3 North America Mycosis Fungoides Treatment Market Share by Application (2019-2030)
6.4 North America Mycosis Fungoides Treatment Market Size by Country
6.4.1 North America Mycosis Fungoides Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Mycosis Fungoides Treatment Market Size by Country (2019-2024)
6.4.3 North America Mycosis Fungoides Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Mycosis Fungoides Treatment Market Size (2019-2030)
7.2 Europe Mycosis Fungoides Treatment Market Size by Type
7.2.1 Europe Mycosis Fungoides Treatment Market Size by Type (2019-2024)
7.2.2 Europe Mycosis Fungoides Treatment Market Size by Type (2025-2030)
7.2.3 Europe Mycosis Fungoides Treatment Market Share by Type (2019-2030)
7.3 Europe Mycosis Fungoides Treatment Market Size by Application
7.3.1 Europe Mycosis Fungoides Treatment Market Size by Application (2019-2024)
7.3.2 Europe Mycosis Fungoides Treatment Market Size by Application (2025-2030)
7.3.3 Europe Mycosis Fungoides Treatment Market Share by Application (2019-2030)
7.4 Europe Mycosis Fungoides Treatment Market Size by Country
7.4.1 Europe Mycosis Fungoides Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Mycosis Fungoides Treatment Market Size by Country (2019-2024)
7.4.3 Europe Mycosis Fungoides Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Mycosis Fungoides Treatment Market Size (2019-2030)
8.2 China Mycosis Fungoides Treatment Market Size by Type
8.2.1 China Mycosis Fungoides Treatment Market Size by Type (2019-2024)
8.2.2 China Mycosis Fungoides Treatment Market Size by Type (2025-2030)
8.2.3 China Mycosis Fungoides Treatment Market Share by Type (2019-2030)
8.3 China Mycosis Fungoides Treatment Market Size by Application
8.3.1 China Mycosis Fungoides Treatment Market Size by Application (2019-2024)
8.3.2 China Mycosis Fungoides Treatment Market Size by Application (2025-2030)
8.3.3 China Mycosis Fungoides Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Mycosis Fungoides Treatment Market Size (2019-2030)
9.2 Asia Mycosis Fungoides Treatment Market Size by Type
9.2.1 Asia Mycosis Fungoides Treatment Market Size by Type (2019-2024)
9.2.2 Asia Mycosis Fungoides Treatment Market Size by Type (2025-2030)
9.2.3 Asia Mycosis Fungoides Treatment Market Share by Type (2019-2030)
9.3 Asia Mycosis Fungoides Treatment Market Size by Application
9.3.1 Asia Mycosis Fungoides Treatment Market Size by Application (2019-2024)
9.3.2 Asia Mycosis Fungoides Treatment Market Size by Application (2025-2030)
9.3.3 Asia Mycosis Fungoides Treatment Market Share by Application (2019-2030)
9.4 Asia Mycosis Fungoides Treatment Market Size by Region
9.4.1 Asia Mycosis Fungoides Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Mycosis Fungoides Treatment Market Size by Region (2019-2024)
9.4.3 Asia Mycosis Fungoides Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Mycosis Fungoides Treatment Introduction
11.1.4 Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.1.5 Astellas Pharma Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mycosis Fungoides Treatment Introduction
11.2.4 Bayer AG Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.2.5 Bayer AG Recent Developments
11.3 Dover Medical and Scientific Equipment, Ltd.
11.3.1 Dover Medical and Scientific Equipment, Ltd. Company Details
11.3.2 Dover Medical and Scientific Equipment, Ltd. Business Overview
11.3.3 Dover Medical and Scientific Equipment, Ltd. Mycosis Fungoides Treatment Introduction
11.3.4 Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.3.5 Dover Medical and Scientific Equipment, Ltd. Recent Developments
11.4 Elorac, Inc.
11.4.1 Elorac, Inc. Company Details
11.4.2 Elorac, Inc. Business Overview
11.4.3 Elorac, Inc. Mycosis Fungoides Treatment Introduction
11.4.4 Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.4.5 Elorac, Inc. Recent Developments
11.5 Kyowa Kirin, Inc.
11.5.1 Kyowa Kirin, Inc. Company Details
11.5.2 Kyowa Kirin, Inc. Business Overview
11.5.3 Kyowa Kirin, Inc. Mycosis Fungoides Treatment Introduction
11.5.4 Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.5.5 Kyowa Kirin, Inc. Recent Developments
11.6 Macopharma
11.6.1 Macopharma Company Details
11.6.2 Macopharma Business Overview
11.6.3 Macopharma Mycosis Fungoides Treatment Introduction
11.6.4 Macopharma Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.6.5 Macopharma Recent Developments
11.7 Soligenix, Inc.
11.7.1 Soligenix, Inc. Company Details
11.7.2 Soligenix, Inc. Business Overview
11.7.3 Soligenix, Inc. Mycosis Fungoides Treatment Introduction
11.7.4 Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.7.5 Soligenix, Inc. Recent Developments
11.8 Varian Medical Systems
11.8.1 Varian Medical Systems Company Details
11.8.2 Varian Medical Systems Business Overview
11.8.3 Varian Medical Systems Mycosis Fungoides Treatment Introduction
11.8.4 Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.8.5 Varian Medical Systems Recent Developments
11.9 Yaupon Therapeutics
11.9.1 Yaupon Therapeutics Company Details
11.9.2 Yaupon Therapeutics Business Overview
11.9.3 Yaupon Therapeutics Mycosis Fungoides Treatment Introduction
11.9.4 Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2019-2024)
11.9.5 Yaupon Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Mycosis Fungoides Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Topical Steroids
    Table 3. Key Players of Mechlorethamine Gel
    Table 4. Key Players of HDAC Inhibitors
    Table 5. Key Players of Monoclonal Antibodies
    Table 6. Key Players of Localized Radiation Therapy
    Table 7. Key Players of Extracorporeal Photopheresis
    Table 8. Key Players of Others
    Table 9. Global Mycosis Fungoides Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Mycosis Fungoides Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Mycosis Fungoides Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Mycosis Fungoides Treatment Market Share by Region (2019-2024)
    Table 13. Global Mycosis Fungoides Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Mycosis Fungoides Treatment Market Share by Region (2025-2030)
    Table 15. Mycosis Fungoides Treatment Market Trends
    Table 16. Mycosis Fungoides Treatment Market Drivers
    Table 17. Mycosis Fungoides Treatment Market Challenges
    Table 18. Mycosis Fungoides Treatment Market Restraints
    Table 19. Global Mycosis Fungoides Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Mycosis Fungoides Treatment Revenue Share by Players (2019-2024)
    Table 21. Global Top Mycosis Fungoides Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Treatment as of 2023)
    Table 22. Global Mycosis Fungoides Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Mycosis Fungoides Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Mycosis Fungoides Treatment, Headquarters and Area Served
    Table 25. Global Key Players of Mycosis Fungoides Treatment, Product and Application
    Table 26. Global Key Players of Mycosis Fungoides Treatment, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Mycosis Fungoides Treatment Revenue Market Share by Type (2019-2024)
    Table 30. Global Mycosis Fungoides Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Mycosis Fungoides Treatment Revenue Market Share by Type (2025-2030)
    Table 32. Global Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Mycosis Fungoides Treatment Revenue Share by Application (2019-2024)
    Table 34. Global Mycosis Fungoides Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Mycosis Fungoides Treatment Revenue Share by Application (2025-2030)
    Table 36. North America Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Mycosis Fungoides Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Mycosis Fungoides Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Mycosis Fungoides Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Mycosis Fungoides Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Mycosis Fungoides Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Mycosis Fungoides Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Mycosis Fungoides Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Mycosis Fungoides Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Mycosis Fungoides Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Mycosis Fungoides Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Mycosis Fungoides Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Mycosis Fungoides Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Mycosis Fungoides Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Mycosis Fungoides Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Mycosis Fungoides Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Mycosis Fungoides Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Mycosis Fungoides Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 68. Astellas Pharma Company Details
    Table 69. Astellas Pharma Business Overview
    Table 70. Astellas Pharma Mycosis Fungoides Treatment Product
    Table 71. Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 72. Astellas Pharma Recent Developments
    Table 73. Bayer AG Company Details
    Table 74. Bayer AG Business Overview
    Table 75. Bayer AG Mycosis Fungoides Treatment Product
    Table 76. Bayer AG Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 77. Bayer AG Recent Developments
    Table 78. Dover Medical and Scientific Equipment, Ltd. Company Details
    Table 79. Dover Medical and Scientific Equipment, Ltd. Business Overview
    Table 80. Dover Medical and Scientific Equipment, Ltd. Mycosis Fungoides Treatment Product
    Table 81. Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 82. Dover Medical and Scientific Equipment, Ltd. Recent Developments
    Table 83. Elorac, Inc. Company Details
    Table 84. Elorac, Inc. Business Overview
    Table 85. Elorac, Inc. Mycosis Fungoides Treatment Product
    Table 86. Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 87. Elorac, Inc. Recent Developments
    Table 88. Kyowa Kirin, Inc. Company Details
    Table 89. Kyowa Kirin, Inc. Business Overview
    Table 90. Kyowa Kirin, Inc. Mycosis Fungoides Treatment Product
    Table 91. Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 92. Kyowa Kirin, Inc. Recent Developments
    Table 93. Macopharma Company Details
    Table 94. Macopharma Business Overview
    Table 95. Macopharma Mycosis Fungoides Treatment Product
    Table 96. Macopharma Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 97. Macopharma Recent Developments
    Table 98. Soligenix, Inc. Company Details
    Table 99. Soligenix, Inc. Business Overview
    Table 100. Soligenix, Inc. Mycosis Fungoides Treatment Product
    Table 101. Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 102. Soligenix, Inc. Recent Developments
    Table 103. Varian Medical Systems Company Details
    Table 104. Varian Medical Systems Business Overview
    Table 105. Varian Medical Systems Mycosis Fungoides Treatment Product
    Table 106. Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 107. Varian Medical Systems Recent Developments
    Table 108. Yaupon Therapeutics Company Details
    Table 109. Yaupon Therapeutics Business Overview
    Table 110. Yaupon Therapeutics Mycosis Fungoides Treatment Product
    Table 111. Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2019-2024) & (US$ Million)
    Table 112. Yaupon Therapeutics Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mycosis Fungoides Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Mycosis Fungoides Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Topical Steroids Features
    Figure 4. Mechlorethamine Gel Features
    Figure 5. HDAC Inhibitors Features
    Figure 6. Monoclonal Antibodies Features
    Figure 7. Localized Radiation Therapy Features
    Figure 8. Extracorporeal Photopheresis Features
    Figure 9. Others Features
    Figure 10. Global Mycosis Fungoides Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Mycosis Fungoides Treatment Market Share by Application: 2023 VS 2030
    Figure 12. Hospitals Case Studies
    Figure 13. Ambulatory Surgical Centers Case Studies
    Figure 14. Others Case Studies
    Figure 15. Mycosis Fungoides Treatment Report Years Considered
    Figure 16. Global Mycosis Fungoides Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Mycosis Fungoides Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Mycosis Fungoides Treatment Market Share by Region: 2023 VS 2030
    Figure 19. Global Mycosis Fungoides Treatment Market Share by Players in 2023
    Figure 20. Global Top Mycosis Fungoides Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycosis Fungoides Treatment as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Mycosis Fungoides Treatment Revenue in 2023
    Figure 22. North America Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Mycosis Fungoides Treatment Market Share by Type (2019-2030)
    Figure 24. North America Mycosis Fungoides Treatment Market Share by Application (2019-2030)
    Figure 25. North America Mycosis Fungoides Treatment Market Share by Country (2019-2030)
    Figure 26. United States Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Mycosis Fungoides Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Mycosis Fungoides Treatment Market Share by Type (2019-2030)
    Figure 30. Europe Mycosis Fungoides Treatment Market Share by Application (2019-2030)
    Figure 31. Europe Mycosis Fungoides Treatment Market Share by Country (2019-2030)
    Figure 32. Germany Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Mycosis Fungoides Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Mycosis Fungoides Treatment Market Share by Type (2019-2030)
    Figure 40. China Mycosis Fungoides Treatment Market Share by Application (2019-2030)
    Figure 41. Asia Mycosis Fungoides Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Mycosis Fungoides Treatment Market Share by Type (2019-2030)
    Figure 43. Asia Mycosis Fungoides Treatment Market Share by Application (2019-2030)
    Figure 44. Asia Mycosis Fungoides Treatment Market Share by Region (2019-2030)
    Figure 45. Japan Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Mycosis Fungoides Treatment Market Share by Country (2019-2030)
    Figure 55. Brazil Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Mycosis Fungoides Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Astellas Pharma Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 62. Bayer AG Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 63. Dover Medical and Scientific Equipment, Ltd. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 64. Elorac, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 65. Kyowa Kirin, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 66. Macopharma Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 67. Soligenix, Inc. Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 68. Varian Medical Systems Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 69. Yaupon Therapeutics Revenue Growth Rate in Mycosis Fungoides Treatment Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS